在一间明亮的公司律师事务所内,一位棕色长发的女士身着黑色西装外套,乳白色衬衣,戴着珍珠耳环,在模糊的室内环境中对着镜头微笑。

乔丹-H-斯迈利

协理

Jordan Smiley is a member of the Health Care Practice Group within Foley & Lardner LLP’s Business Law Department. She is based in the Los Angeles office.

Jordan’s knowledge covers a wide range of regulatory guidance within the health care sector. She has a thorough understanding of reproductive health care regulations, ensuring compliance with laws governing the evolving legal landscape. Additionally, Jordan is well-versed in telehealth regulations, an assists start-up companies in developing policies and procedures that adhere to complex health care requirements. Furthermore, Jordan is skilled in addressing consent laws, ensuring providers are protected and patient safety is prioritized from the onset of a patient-provider relationship. Jordan is also adept at addressing disciplinary actions in response to medical board inquiries and staying abreast of state-sponsored initiatives and waiver programs. In terms of transactional work, Jordan has experience in health care mergers and acquisitions and drafting meticulous employment agreements tailored to the unique needs of health care professionals.

Jordan began her career at Foley & Lardner LLP as a summer associate in 2022. Prior to joining Foley, Jordan worked as a case manager at a litigation firm where she oversaw third-party communications, evidence collection, and preparation of court filings. Jordan also worked at Disability Rights California where she served as an advocate for clients seeking at-home healthcare via Medicaid.

社区参与

  • Volunteer, Foxy and the Hounds, a local Southern California non-profit that serves to rehabilitate injured, neglected, and abused dogs at risk of euthanasia

演讲和出版物

June 5, 2024 In the News

Foley Attorneys Author Overview of Critical Year for 340B Drug Pricing Program

Foley & Lardner LLP partners Anil Shankar and Adria Warren and associate Jordan Smiley authored the Pharmaceutical Commerce article, "Critical Year Ahead for the 340B Drug Pricing Program."
一支移液管将液体注入一个放置在数字 DNA 测序图案上的培养皿中,图案上有彩色条纹,突显了生物技术创新与知识产权法的交集。
2024 年 4 月 29 日 今日医疗保健法

2024 年医疗保健与生命科学的主要趋势

Foley & Lardner 的《2024 年医疗保健与生命科学最热门趋势》出版物解读了快速发展的趋势,为您的业务提供帮助。
A large assortment of colorful pills and tablets in various shapes and sizes spread out in a random pile, much like the array of expertise you’d find at top corporate law offices or among skilled lawyers in Chicago.
April 1, 2024 Health Care Law Today

FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness

The FDA has recently issued guidance for sponsors and investigators interested in submitting a non-interventional study, commonly known as an observational study, to contribute evidence of a drug’s safety and effectiveness.
A doctor in a white coat shakes hands with a person in a suit, suggesting a professional agreement or partnership between medical professionals and a corporate law office in a clinical setting.
March 27, 2024 Health Care Law Today

Health-Related Social Needs: Three Trends in Leveraging Community Partnerships

Three trends in community partnerships to address the struggle with interventions to impact individuals’ health-related social needs (HRSN).
March 22, 2024 Press Releases

洛杉矶富里为男孩女孩俱乐部学生参加年度青年竞赛做准备

Foley & Lardner LLP 合伙人 Nicholas Gross 和律师 Trevor Mullin、Kathryn Petrosky、Jordan Smiley、Savannah Levin、Troy Tessem 和 Tam Wheat 帮助洛杉矶大都会男孩女孩俱乐部的学生为年度青年竞赛做准备。
一位佩戴安全护目镜和手套的科学家正在显微镜下检查样本,这恰如其分地体现了顶尖律所知识产权法律实务中的严谨性。
March 14, 2024 Health Care Law Today

Clinical Research: FDA Issues Draft Guidance on Informed Consent

The U.S. Food and Drug Administration, in collaboration other agencies, recently published draft guidance on effectively presenting key information regarding informed consent in FDA-regulated clinical investigations of medical products and Department of Health and Human Services supported human subjects research.